What is VBI Vaccines Inc (VBIV) stock price today?

VBI Vaccines Inc (VBIV) currently trades at $0.07 per share. The stock has a market capitalization of $1.87M and a P/E ratio of —x.

Is VBIV stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, VBI Vaccines Inc has a Smart Value Score of 40/100 (Grade D), resulting in a "Sell" investment rating. The Piotroski F-Score is —/9 and Altman Z-Score is —.

What is VBI Vaccines Inc's revenue and earnings?

VBI Vaccines Inc has trailing twelve-month (TTM) revenue of $9.41M with profit margins of 0.00%. Earnings per share (EPS) is $-3.54.

VBIV

VBI Vaccines Inc

NASDAQ: VBIV · HEALTHCARE · BIOTECHNOLOGY

$0.07

+0.00% today

Updated 2026-04-30

Market cap

$1.87M

P/E ratio

—

P/S ratio

0.20x

EPS (TTM)

$-3.54

Dividend yield

—

52W range

$0 – $0

Volume

—

Market cap

$1.87M

P/E ratio

—

P/S ratio

0.20x

EPS (TTM)

$-3.54

Dividend yield

—

52W range

$0 – $0

Volume

—

WallStSmart proprietary scores

out of 100

Grade: D

Sell

Investment rating

8.0

Growth

5.0

Quality

C+

2.5

Profitability

5.0

Valuation

C+

—/9

Piotroski F-Score

—

Altman Z-Score

—

Industry rank

—

View all highly rated stocks (75+) →206 stocks currently score above 75

Price targets

Analyst target

$5.00

+7556.97%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

X-Ray snapshot

Strengths

+ Revenue growth 150.30% QoQ

Risks

- Thin margins at 0.00%

- Negative free cash flow $-11.92M

Key financials

Revenue Net Income Free Cash Flow

Metric	2020	2021	2022	2023	TTM
Revenue	$1.06M	$631000.00	$1.08M	$8.68M	$9.41M
Net income	$-47.29M	$-72.65M	$-140.95M	$-92.84M	$-17.90M
EPS	—	—	—	—	$-3.54
Free cash flow	$-48.05M	$-41.90M	$-78.04M	$-61.75M	$-11.92M
Profit margin	-4,456.74%	-11,513.47%	-13,026.89%	-1,069.29%	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
VBIV	$1.87M	40	8.0	2.5	5.0	5.0	—	Hold
LLY	$760.43B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.28B	59	4.7	9.0	3.3	6.0	-43.54%	Buy
ABBV	$360.63B	63	4.0	8.0	4.7	5.0	-29.31%	Buy
UNH	$336.47B	54	5.3	5.5	7.3	4.8	+42.09%	Buy
AZN	$287.11B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

VBI Vaccines Inc trades at $0.07. Our Smart Value Score of 40/100 indicates the stock is fair. TTM revenue stands at $9.41M.

Frequently asked questions

What is VBI Vaccines Inc's stock price?

VBI Vaccines Inc (VBIV) trades at $0.07.

Is VBI Vaccines Inc overvalued?

Smart Value Score 40/100 (Grade D, Sell).

What is the price target of VBI Vaccines Inc (VBIV)?

The analyst target price is $5.00, representing +7557.0% upside from the current price of $0.07.

What is VBI Vaccines Inc's revenue?

TTM revenue is $9.41M.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio0.20x

ROE-419.60%

Beta2.17

50D MA$0.48

200D MA$0.58

Shares out0.03B

Float0.03B

Short ratio—

Avg volume—

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

VBIV vs LLY →VBIV vs JNJ →VBIV vs ABBV →Stock screener →